Mark E. Rose, MD

Mark E. Rose, MD
Section of Adult Allergy and Immunology, Department of Pulmonary, Allergy, and Critical Care Medicine, The Cleveland Clinic Foundation

David M. Lang, MD
Head, Section of Adult Department of Allergy and Immunology, Department of Pulmonary, Allergy, and Critical Care Medicine, The Cleveland Clinic Foundation

Address: David M. Lang, MD, Department of Allergy and Immunology, C22, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

Dr. Lang has indicated that he has received honoraria from, has served as a consultant for, or has carried out clinical research with the AstraZeneca, Aventis, Genetech, GlaxoSmithKline, Ivax, Merck, Novartis, Pfizer, and Schering/Key corporations.

Mark E. Rose, MD
Section of Adult Allergy and Immunology, Department of Pulmonary, Allergy, and Critical Care Medicine, The Cleveland Clinic Foundation

David M. Lang, MD
Head, Section of Adult Department of Allergy and Immunology, Department of Pulmonary, Allergy, and Critical Care Medicine, The Cleveland Clinic Foundation

Address: David M. Lang, MD, Department of Allergy and Immunology, C22, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

Dr. Lang has indicated that he has received honoraria from, has served as a consultant for, or has carried out clinical research with the AstraZeneca, Aventis, Genetech, GlaxoSmithKline, Ivax, Merck, Novartis, Pfizer, and Schering/Key corporations.

Mark E. Rose, MD
Section of Adult Allergy and Immunology, Department of Pulmonary, Allergy, and Critical Care Medicine, The Cleveland Clinic Foundation

David M. Lang, MD
Head, Section of Adult Department of Allergy and Immunology, Department of Pulmonary, Allergy, and Critical Care Medicine, The Cleveland Clinic Foundation

Address: David M. Lang, MD, Department of Allergy and Immunology, C22, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

Dr. Lang has indicated that he has received honoraria from, has served as a consultant for, or has carried out clinical research with the AstraZeneca, Aventis, Genetech, GlaxoSmithKline, Ivax, Merck, Novartis, Pfizer, and Schering/Key corporations.